Adverse events should be reported
Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/.
Adverse events should also be reported to Luye Pharma Ltd. at safety@luyepharma.co.uk.
Seroquel XL® and Seroquel®
(quetiapine)
Seroquel® (quetiapine) is for the treatment of schizophrenia, moderate to severe manic episodes in bipolar disorder, major depressive episodes in bipolar disorder and preventing recurrence of manic or depressed episodes in patients with bipolar disorder who previously responded to quetiapine.
Find out more
Fencino®
(fentanyl)
Fencino® (fentanyl) is a transdermal patch indicated for management of severe chronic pain that requires continuous long-term opioid administration. The Fencino® patch should be replaced every 72 hours.
Find out more
Zeyzelf®
(rivastigmine)
Zeyzelf® (rivastigmine) is a twice weekly transdermal patch indicated for the symptomatic treatment of mild to moderately severe Alzheimer’s dementia. The Zeyzelf® patch should be replaced twice weekly on fixed days (after four and three days, respectively).
Find out more